Latest Headlines

  1. Roche Expands Long-Term Alliance With Sysmex 8/3/2023

    Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the expansion of their Global Business Partnership Agreement with Sysmex. As part of the renewed framework, the companies strengthen their commitment to their long-standing partnership.

  2. Labcorp Forges Strategic Partnership With Tufts Medicine, Will Acquire Outreach Laboratory Business 8/3/2023

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an agreement with Tufts Medicine, a leading integrated academic health system in Massachusetts, for Labcorp to acquire the Tufts Medicine outreach laboratory business and select operating assets as a first step toward a larger strategic partnership.

  3. Sapient’s High Complexity CLIA Laboratory Receives Accreditation From The College Of American Pathologists (CAP) 8/2/2023

    Sapient, a biomarker discovery organization providing bespoke services for metabolomics and lipidomics data generation and analysis, announced that its high complexity CLIA laboratory has been awarded accreditation from the College of American Pathologists (CAP).

  4. PacBio Begins Commercialization Of The Onso Short-Read Sequencing System 8/2/2023

    PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that customer shipments of Onso short-read sequencing instruments will commence today.

  5. Prometheus Laboratories Announces Collaboration With Fresenius Kabi On Anser Testing 8/1/2023

    Prometheus Laboratories Inc. ("Prometheus") today announced a collaboration with Fresenius Kabi to support the validation of and access to Anser® therapeutic drug monitoring (TDM) services for eligible patients receiving the Fresenius Kabi biosimilar, IDACIO® (adalimumab-aacf).

  6. Mainz Biomed Announces Live Launch Of ColoAlert® With Marylebone Laboratory In The United Kingdom 8/1/2023

    Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that London-based Marylebone Laboratory (Marylebone Lab Ltd) has introduced ColoAlert®, Mainz Biomed’s flagship product, a highly effective and user-friendly at-home detection test for colorectal cancer (CRC) - to its extensive UK and international customer base.

  7. BD Receives 510(k) Clearance For COVID-19, Influenza A/B, RSV Molecular Combination Test 8/1/2023

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the BD Respiratory Viral Panel (RVP) for BD MAX™ System, a single molecular diagnostic combination test that identifies and distinguishes SARS-CoV-2, influenza A, influenza B, and Respiratory Syncytial Virus (RSV) in approximately two hours.

  8. Terumo Blood and Cell Technologies' Reveos® Automated Whole Blood Processing System Cleared By FDA For U.S. Commercial Use 8/1/2023

    Terumo Blood and Cell Technologies (Terumo BCT) announces U.S. Food and Drug Administration (FDA) clearance of the Reveos Automated Whole Blood Processing System, the first whole blood automation device available in the U.S. that processes whole blood into platelets and other components in a single centrifugation cycle.

  9. Quest Introduces First-To-Market Consumer-Initiated Blood Test For Alzheimer's Disease Risk Assessment On Questhealth.com 7/31/2023

    Quest Diagnostics (NYSE: DGX), the leader in diagnostic information services, today announced the availability of the AD-Detect™ Test for Alzheimer's Disease on questhealth.com – the first blood test available for consumer purchase that helps assess potential risk of developing Alzheimer's disease based on a brain protein that contributes to the condition.*

  10. Know Labs Demonstrates Improved Accuracy Of Machine Learning Model For Non-Invasive Glucose Monitor 7/26/2023

    Know Labs, Inc. today announced results from a new study titled, “Novel data preprocessing techniques in an expanded dataset improve machine learning model accuracy for a non-invasive blood glucose monitor.”